Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Organogenesis Holdings (ORGO) Return on Capital Employed (2017 - 2025)

Organogenesis Holdings (ORGO) has 9 years of Return on Capital Employed data on record, last reported at 0.1% in Q4 2025.

  • For Q4 2025, Return on Capital Employed rose 10.0% year-over-year to 0.1%; the TTM value through Dec 2025 reached 0.1%, up 10.0%, while the annual FY2025 figure was 0.1%, 10.0% up from the prior year.
  • Return on Capital Employed reached 0.1% in Q4 2025 per ORGO's latest filing, up from 0.02% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 0.32% in Q2 2021 and bottomed at 0.06% in Q1 2025.
  • Average Return on Capital Employed over 5 years is 0.08%, with a median of 0.05% recorded in 2022.
  • Peak YoY movement for Return on Capital Employed: soared 76bps in 2021, then decreased -19bps in 2022.
  • A 5-year view of Return on Capital Employed shows it stood at 0.22% in 2021, then crashed by -74bps to 0.06% in 2022, then tumbled by -44bps to 0.03% in 2023, then tumbled by -110bps to 0.0% in 2024, then skyrocketed by 3127bps to 0.1% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Capital Employed were 0.1% in Q4 2025, 0.02% in Q3 2025, and 0.06% in Q2 2025.